Home
>
National Drug Code (NDC)
>
Linzess
Linzess - 0456-1201-30 - (linaclotide)
Drug Information of Linzess
| Product NDC: | 0456-1201 |
| Proprietary Name: | Linzess |
| Non Proprietary Name: | linaclotide |
| Active Ingredient(s): | 145 ug/1 & nbsp; linaclotide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, GELATIN COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Linzess
| Product NDC: | 0456-1201 |
| Labeler Name: | Forest Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA202811 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20120908 |
Package Information of Linzess
| Package NDC: | 0456-1201-30 |
| Package Description: | 1 BOTTLE in 1 CARTON (0456-1201-30) > 30 CAPSULE, GELATIN COATED in 1 BOTTLE |
NDC Information of Linzess
| NDC Code | 0456-1201-30 |
| Proprietary Name | Linzess |
| Package Description | 1 BOTTLE in 1 CARTON (0456-1201-30) > 30 CAPSULE, GELATIN COATED in 1 BOTTLE |
| Product NDC | 0456-1201 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | linaclotide |
| Dosage Form Name | CAPSULE, GELATIN COATED |
| Route Name | ORAL |
| Start Marketing Date | 20120908 |
| Marketing Category Name | NDA |
| Labeler Name | Forest Laboratories, Inc. |
| Substance Name | LINACLOTIDE |
| Strength Number | 145 |
| Strength Unit | ug/1 |
| Pharmaceutical Classes | Guanylate Cyclase-C Agonist [EPC],Guanylate Cyclase Activators [MoA] |
